Gilead to give licensees in India support to open more Remdesivir manufacturing facilities
Gilead to give licensees in India support to open more Remdesivir manufacturing facilities ANI | Updated: Apr 29, 2021 16:30 IST California [US], April 29 (ANI/Sputnik): US-basedGilead Sciences Inc company, the developer of antiviral drug Remdesivir, used for treatment of COVID-19 patients, will provide all its licensing partners in coronavirus-hit India with the technical support for the addition of new manufacturing facilities but will not send any more specialists there, a Gilead spokesperson told Sputnik. On Monday, Gilead announced steps to boost ...